Pulmonary Circulation (Oct 2021)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients

  • Eva L. Peters,
  • Jasmijn S.J.A vanCampen,
  • Herman Groepenhoff,
  • Frances S. deMan,
  • Anton Vonk Noordegraaf,
  • Harm J. Bogaard

DOI
https://doi.org/10.1177/20458940211057890
Journal volume & issue
Vol. 11, no. 4
pp. 1 – 4

Abstract

Read online

Hyperventilation is common in pulmonary arterial hypertension and may be related to autonomic imbalance. Patients underwent exercise testing and hyperoxic breathing before and after bisoprolol treatment. We found that neither beta blocker treatment nor hyperoxic breathing in patients reduced hyperventilation at rest and during exercise, although it reduced heart rate.

Keywords